Gap Junction–Mediated Transport of Metabolites Between Stem Cells and Vascular Endothelial Cells. (November 2022)

• Record Type: Journal Article
• Authors: Ogawa, Yuko; Akamatsu, Rie; Fuchizaki, Akihiro; Yasui, Kazuta; Saino, Orie; Tanaka, Mitsunobu; Kikuchi-Taura, Akie; Kimura, Takafumi; Taguchi, Akihiko
• Is Part Of: Cell transplantation. Volume 31(2022)
• Publication Date: 2022-11
• Subjects: hematopoietic stem cells -- mesenchymal stem cells -- human umbilical vein endothelial cells -- circulating CD34-negative and CD45-positive white blood cells -- gap junction; Cell transplantation -- Periodicals; Cell Transplantation; Cell transplantation; Electronic journals; Periodicals; Periodicals; 571.638
• DOI: 10.1177/09636897221136151
• Languages: English
• ISSNs: 0963-6897

Abstract

We have previously demonstrated that small molecular transfer, such as glucose, between hematopoietic stem cells (HSCs) or mesenchymal stem cells (MSCs) and vascular endothelial cells via gap junctions constitutes an important mechanism of stem cell therapy. Cell metabolites are high-potential small-molecule candidates that can be transferred to small molecules between stem cells and vascular endothelial cells. Here, we investigated the differences in metabolite levels between stem cells (HSCs and MSCs), vascular endothelial cells, and the levels of circulating non-hematopoietic white blood cells (WBCs). The results showed remarkable differences in metabolite concentrations between cells. Significantly higher concentrations of adenosine triphosphate (ATP), guanosine triphosphate (GTP), total adenylate or guanylate levels, glycolytic intermediates, and amino acids were found in HSCs compared with vascular endothelial cells. In contrast, there was no significant difference in the metabolism of MSCs and vascular endothelial cells. From the results of this study, it became clear that HSCs and MSCs differ in their metabolites. That is, metabolites that transfer between stem cells and vascular endothelial cells differ between HSCs and MSCs. HSCs may donate various metabolites, several glycolytic and tricarboxylic acid cycle metabolites, and amino acids to damaged vascular endothelial cells as energy sources and activate the energy metabolism of vascular endothelial cells. In contrast, MSCs and vascular endothelial cells regulate each other under normal conditions. As the existing MSCs cannot ameliorate the dysregulation during insult, exogenous MSCs administered by cell therapy may help restore normal metabolic function in the vascular endothelial cells by taking up excess energy sources from the lumens of blood vessels. Results of this study suggested that the appropriate timing of cell therapy is different between HSCs and MSCs.